This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2003 Feb;3(2):70.

doi: 10.1016/s1473-3099(03)00512-7.

Miltefosine in visceral leishmaniasis

Piero L Olliaro, Robert G Ridley, Jurgen Engel, Herbert Sindermann, Anthony D M Bryceson

PMID: 12560189
DOI: 10.1016/s1473-3099(03)00512-7

Comment

Miltefosine in visceral leishmaniasis

Piero L Olliaro et al. Lancet Infect Dis. 2003 Feb.

. 2003 Feb;3(2):70.

doi: 10.1016/s1473-3099(03)00512-7.

Authors

Piero L Olliaro, Robert G Ridley, Jurgen Engel, Herbert Sindermann, Anthony D M Bryceson

PMID: 12560189
DOI: 10.1016/s1473-3099(03)00512-7

No abstract available

PubMed Disclaimer

Comment on

Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda.
Guerin PJ, Olliaro P, Sundar S, Boelaert M, Croft SL, Desjeux P, Wasunna MK, Bryceson AD. Guerin PJ, et al. Lancet Infect Dis. 2002 Aug;2(8):494-501. doi: 10.1016/s1473-3099(02)00347-x. Lancet Infect Dis. 2002. PMID: 12150849 Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science